Breaking News, Financial News

Financial Report: Allergan 1Q

Specialty pharmaceutical sales increased 10% to $907.3 million in the quarter.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan 1Q 1Q Revenues: $1.1 billion (+11%) 1Q Earnings: $169.0 million (earnings were $45.0 million in 1Q09) Comments: Specialty pharmaceutical sales increased 10% to $907.3 million in the quarter. Top sellers, Restasis and the Lumigan Franchise, achieved growth of 23% and 18%, respectively. Restasis sales totaled $133.4 million and Lumigan sales were $119.6 million. Total medical device sales were up 18% percent to $198.5 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters